Value: The Four Cornerstones of Corporate Finance
McKinsey & Company Inc, Koller, Tim, Dobbs, Richard
- 出版商: Wiley
- 出版日期: 2010-11-09
- 售價: $1,300
- 貴賓價: 9.5 折 $1,235
- 語言: 英文
- 頁數: 272
- 裝訂: Hardcover - also called cloth, retail trade, or trade
- ISBN: 0470424605
- ISBN-13: 9780470424605
海外代購書籍(需單獨結帳)
相關主題
商品描述
While you can find numerous books focused on the topic of corporate finance, few offer the type of information managers need to help them make important decisions day in and day out.
Value explores the core of corporate finance without getting bogged down in numbers and is intended to give managers an accessible guide to both the foundations and applications of corporate finance. Filled with in-depth insights from experts at McKinsey & Company, this reliable resource takes a much more qualitative approach to what the authors consider a lost art.
- Discusses the four foundational principles of corporate finance
- Effectively applies the theory of value creation to our economy
- Examines ways to maintain and grow value through mergers, acquisitions, and portfolio management
- Addresses how to ensure your company has the right governance, performance measurement, and internal discussions to encourage value-creating decisions
A perfect companion to the Fifth Edition of Valuation, this book will put the various issues associated with corporate finance in perspective.
作者簡介
TIM KOLLER leads the firm's research activities in valuation and capital market issues. He advises clients globally on corporate strategy, capital markets, M&A, and value-based management. Tim is a coauthor of Valuation: Measuring and Managing the Value of Companies.
RICHARD DOBBS is a director of the McKinsey Global Institute, the firm's business and economics research arm. He advises Korean and other Asian companies and governments on strategy, economics, and M&A issues. Richard is an associate fellow of University of Oxford's Saïd Business School.
BILL HUYETT advises clients in healthcare and other technology-intensive industries on corporate strategy, M&A, product development and commercialization, and corporate leadership. Bill is active on several not-for-profit boards in basic life sciences research.